Cargando…

sFgl2-Treg Positive Feedback Pathway Protects against Atherosclerosis

Soluble fibrinogen-like protein 2 (sFgl2), a novel effector of regulatory T cells (Tregs), has been demonstrated to have potent immunosuppressive functions. Multiple studies indicate that Tregs could exert important atheroprotective effects, but their numbers gradually decrease during atherogenesis....

Descripción completa

Detalles Bibliográficos
Autores principales:	An, Tianhui, Guo, Mengyuan, Fan, Cheng, Huang, Shiyuan, Liu, Hui, Liu, Kun, Wang, Zhaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916961/ https://www.ncbi.nlm.nih.gov/pubmed/36768661 http://dx.doi.org/10.3390/ijms24032338

Ejemplares similares

Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation
por: Liu, Xin-guang, et al.
Publicado: (2016)

sFgl2 gene-modified MSCs regulate the differentiation of CD4(+) T cells in the treatment of autoimmune hepatitis
por: Ji, Wenbin, et al.
Publicado: (2023)

Regulatory T cells induce polarization of pro-repair macrophages by secreting sFGL2 into the endometriotic milieu
por: Hou, Xin-Xin, et al.
Publicado: (2021)

Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2
por: Fu, Yong, et al.
Publicado: (2020)

Mesenchymal stem cells transfected with sFgl2 inhibit the acute rejection of heart transplantation in mice by regulating macrophage activation
por: Gao, Chao, et al.
Publicado: (2020)

FGL2 is positively correlated with enhanced antitumor responses mediated by T cells in lung adenocarcinoma
por: Yuan, Kai, et al.
Publicado: (2020)

Abnormal Expression of the LAG-3/FGL-1 Signaling Pathway in Patients with Early-Onset Preeclampsia
por: Liang, Yue, et al.
Publicado: (2022)

Xue-Jie-San restricts ferroptosis in Crohn’s disease via inhibiting FGL1/NF-κB/STAT3 positive feedback loop
por: Gao, Ying, et al.
Publicado: (2023)

Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis
por: Tang, Xi-Yang, et al.
Publicado: (2022)

Fgl2: link between hepatitis B and SARS?
por: Robertson, Morag
Publicado: (2003)

Targeting FGL2 in glioma immunosuppression and malignant progression
por: Ma, Xiaoyu, et al.
Publicado: (2022)

Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
por: Shi, An-Ping, et al.
Publicado: (2022)

Th17/Treg Imbalance and Atherosclerosis
por: He, Xin, et al.
Publicado: (2020)

The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer
por: Li, Jia-Jun, et al.
Publicado: (2023)

The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection
por: Shalev, Itay, et al.
Publicado: (2010)

Dynamics of Functionally Graded Laminated (FGL) Media—Theoretical Tolerance Modelling
por: Jędrysiak, Jarosław
Publicado: (2023)

Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4(+) CD25(+) Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice
por: Wang, Junhua, et al.
Publicado: (2015)

Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target
por: Qian, Wenjing, et al.
Publicado: (2021)

Non-HDL-cholesterol to HDL-cholesterol ratio is an independent risk factor for liver function tests abnormalities in geriatric population
por: An, Tianhui, et al.
Publicado: (2018)

FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer
por: Sun, Cuilan, et al.
Publicado: (2020)

FGL-GAN: Global-Local Mask Generative Adversarial Network for Flame Image Composition
por: Qin, Kui, et al.
Publicado: (2022)

Protective effect of irisin against Alzheimer’s disease
por: Chen, Kang, et al.
Publicado: (2022)

Identification of the Receptor for FGL2 and Implications for Susceptibility to Mouse Hepatitis Virus (MHV-3)-Induced Fulminant Hepatitis
por: Liu, Hao, et al.
Publicado: (2006)

FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation
por: Yan, Jun, et al.
Publicado: (2019)

The Fgl2 interaction with Tyrobp promotes the proliferation of cutaneous squamous cell carcinoma by regulating ERK-dependent autophagy
por: Zeng, Mei, et al.
Publicado: (2022)

miR-146b suppresses LPS-induced M1 macrophage polarization via inhibiting the FGL2-activated NF-κB/MAPK signaling pathway in inflammatory bowel disease
por: Pan, Yang, et al.
Publicado: (2022)

Porphyromonas gingivalis oral infection promote T helper 17/Treg imbalance in the development of atherosclerosis
por: Yang, Jie, et al.
Publicado: (2017)

FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma
por: Lv, Zheng, et al.
Publicado: (2021)

Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma
por: Yan, Qing, et al.
Publicado: (2022)

Blockade of Macrophage CD147 Protects Against Foam Cell Formation in Atherosclerosis
por: Lv, Jian-Jun, et al.
Publicado: (2021)

Ivermectin Protects Against Experimental Autoimmune Encephalomyelitis in Mice by Modulating the Th17/Treg Balance Involved in the IL-2/STAT5 Pathway
por: Xie, Yu, et al.
Publicado: (2023)

Lack of RAC1 in macrophages protects against atherosclerosis
por: Bandaru, Sashidar, et al.
Publicado: (2020)

FABP4 facilitates inflammasome activation to induce the Treg/Th17 imbalance in preeclampsia via forming a positive feedback with IL-17A
por: Chang, Guang-Ping, et al.
Publicado: (2021)

Insulin-binding protein-5 down-regulates the balance of Th17/Treg
por: Zhu, Mengyuan, et al.
Publicado: (2022)

Pilicides inhibit the FGL chaperone/usher assisted biogenesis of the Dr fimbrial polyadhesin from uropathogenic Escherichia coli
por: Piatek, Rafał, et al.
Publicado: (2013)

Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation
por: Yan, Jun, et al.
Publicado: (2019)

Fibrinogen-Like Protein 2 (FGL2) is a Novel Biomarker for Clinical Prediction of Human Breast Cancer
por: Feng, Yanyan, et al.
Publicado: (2020)

Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis
por: Denicolò, Sara, et al.
Publicado: (2022)

Sleep modulates hematopoiesis and protects against atherosclerosis
por: McAlpine, Cameron S., et al.
Publicado: (2019)

Chaperone-mediated autophagy protects against atherosclerosis
por: Madrigal-Matute, Julio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rb2m576f23j033t3pmdbev450s